BIRC5 and breast cancer: Fibroblasts are known to become activated by survivin within EVs, where they upregulate superoxide dismutase 1 (SOD1), converting them into myofibroblasts which promote BC progression and metastasis, indicating that targeting this pathway may constitute a potential therapy in BC [75].